Human KRT14(Keratin 14) ELISA Kit
Human Keratin 14 (KRT14) ELISA Kit |
|||
RDR-KRT14-Hu-48Tests | Reddot Biotech | 48 Tests | 600 EUR |
Human Keratin 14 (KRT14) ELISA Kit |
|||
RDR-KRT14-Hu-96Tests | Reddot Biotech | 96 Tests | 830.4 EUR |
Human Keratin 14 (KRT14) ELISA Kit |
|||
20-abx152107 | Abbexa |
|
|
Human Keratin 14(KRT14)ELISA Kit |
|||
QY-E02833 | Qayee Biotechnology | 96T | 433.2 EUR |
Human Keratin 14 (KRT14) ELISA Kit |
|||
SEA522Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5128.02 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Keratin 14 (KRT14) ELISA Kit |
|||
SEA522Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 527.48 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Keratin 14 (KRT14) ELISA Kit |
|||
SEA522Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 702.12 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Keratin 14 (KRT14) ELISA Kit |
|||
SEA522Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 2799.54 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Keratin 14 (KRT14) ELISA Kit |
|||
4-SEA522Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Keratin 14 (KRT14) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Keratin 14 ELISA Kit (KRT14) |
|||
RK01739 | Abclonal | 96 Tests | 625.2 EUR |
Keratin 14 (KRT14) Antibody |
|||
20-abx109314 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx173244 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
abx146144-100ug | Abbexa | 100 ug | 469.2 EUR |
Keratin 14 (KRT14) Antibody |
|||
20-abx130248 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx128714 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx113336 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx129637 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx007358 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx002877 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx326445 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx327450 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx241010 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody |
|||
20-abx241011 | Abbexa |
|
|
Recombinant Keratin 14 (KRT14) |
|||
4-RPA522Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Keratin 14 expressed in: E.coli |
|||
Recombinant Keratin 14 (KRT14) |
|||
4-RPA522Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Keratin 14 expressed in: E.coli |
|||
Recombinant Keratin 14 (KRT14) |
|||
4-RPA522Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Keratin 14 expressed in: E.coli |
|||
ELISA kit for Human KRT14 (Keratin 14) |
|||
ELK3888 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Keratin 14 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Human Keratin 14 (KRT14) CLIA Kit |
|||
20-abx491574 | Abbexa |
|
|
Human Keratin 14 (KRT14) Protein |
|||
20-abx166632 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody (HRP) |
|||
20-abx108445 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody (Biotin) |
|||
20-abx105606 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody (FITC) |
|||
20-abx107024 | Abbexa |
|
|
Rat Keratin 14 (KRT14) Protein |
|||
20-abx167739 | Abbexa |
|
|
Mouse Keratin 14 (KRT14) Protein |
|||
20-abx168376 | Abbexa |
|
|
Keratin 14 (KRT14) Antibody (FITC) |
|||
abx415614-01mg | Abbexa | 0.1 mg | 610.8 EUR |
Human Keratin, type I cytoskeletal 14, KRT14 ELISA KIT |
|||
ELI-37134h | Lifescience Market | 96 Tests | 988.8 EUR |
Human Keratin, type I cytoskeletal 14 (KRT14) |
|||
1-CSB-EP012512HU | Cusabio |
|
|
Description: Recombinant Human Keratin, type I cytoskeletal 14(KRT14) expressed in E.coli |
|||
Human KeRatin, type I cytoskeletal 14 (KRT14) |
|||
1-CSB-YP012512HU | Cusabio |
|
|
Description: Recombinant Human KeRatin, type I cytoskeletal 14(KRT14) expressed in Yeast |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat) |
|||
4-PAA522Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14) |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat) |
|||
4-PAA522Ra01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14) |
|||
ELISA kit for Human Keratin, type I cytoskeletal 14 (KRT14) |
|||
KTE61884-48T | Abbkine | 48T | 398.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 14 (KRT14) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type I cytoskeletal 14 (KRT14) |
|||
KTE61884-5platesof96wells | Abbkine | 5 plates of 96 wells | 2538 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 14 (KRT14) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type I cytoskeletal 14 (KRT14) |
|||
KTE61884-96T | Abbkine | 96T | 646.8 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 14 (KRT14) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Chicken Keratin, type I cytoskeletal 14, KRT14 ELISA KIT |
|||
ELI-12809c | Lifescience Market | 96 Tests | 1113.6 EUR |
Bovine Keratin, type I cytoskeletal 14, KRT14 ELISA KIT |
|||
ELI-13309b | Lifescience Market | 96 Tests | 1113.6 EUR |
Mouse Keratin, type I cytoskeletal 14, Krt14 ELISA KIT |
|||
ELI-13310m | Lifescience Market | 96 Tests | 1038 EUR |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC |
|||
4-PAA522Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Biotinylated |
|||
4-PAA522Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Biotin. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Cy3 |
|||
4-PAA522Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Cy3. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), FITC |
|||
4-PAA522Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with FITC. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), HRP |
|||
4-PAA522Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with HRP. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), PE |
|||
4-PAA522Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with PE. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC |
|||
4-PAA522Ra01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Biotinylated |
|||
4-PAA522Ra01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Biotin. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Cy3 |
|||
4-PAA522Ra01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Cy3. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), FITC |
|||
4-PAA522Ra01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with FITC. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), HRP |
|||
4-PAA522Ra01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with HRP. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), PE |
|||
4-PAA522Ra01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with PE. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC-Cy7 |
|||
4-PAA522Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC-Cy7. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig) |
|||
4-PAA522Mu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14) |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC-Cy7 |
|||
4-PAA522Ra01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC-Cy7. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), APC |
|||
4-PAA522Mu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with APC. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), Biotinylated |
|||
4-PAA522Mu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with Biotin. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), Cy3 |
|||
4-PAA522Mu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with Cy3. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), FITC |
|||
4-PAA522Mu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with FITC. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), HRP |
|||
4-PAA522Mu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with HRP. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), PE |
|||
4-PAA522Mu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with PE. |
|||
Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), APC-Cy7 |
|||
4-PAA522Mu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with APC-Cy7. |
|||
Keratin 14 Cell ELISA Kit |
|||
abx595639-96tests | Abbexa | 96 tests | 764.4 EUR |
KRT14 Cytokeratin 14 Human Recombinant Protein |
|||
PROTP02533 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: Cytokeratin 14 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain having a molecular mass of 51,530 Dalton. ;The KRT14 is purified by proprietary chromatographic techniques. |
|||
Krt14/ Rat Krt14 ELISA Kit |
|||
ELI-37135r | Lifescience Market | 96 Tests | 1063.2 EUR |
Keratin 14 antibody |
|||
70R-31248 | Fitzgerald | 100 ug | 392.4 EUR |
Description: Rabbit polyclonal Keratin 14 antibody |
|||
Keratin 14 Antibody |
|||
ABF0736 | Lifescience Market | 100 ug | 525.6 EUR |
Keratin 14 Antibody |
|||
ABF5225 | Lifescience Market | 100 ug | 525.6 EUR |
Keratin 14 Antibody |
|||
ABF5370 | Lifescience Market | 100 ug | 525.6 EUR |
Keratin-14 Antibody |
|||
F49812-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
Keratin-14 Antibody |
|||
F49812-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCA0532-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), APC conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCAP0532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCAP0532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC610532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC610532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC680532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC680532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCR0532-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), RPE conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNUB0532-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Concentration: 0.2mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNUB0532-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Concentration: 0.2mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC430532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC430532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC400532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC400532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC880532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC880532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC810532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC810532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCP0532-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNUM0532-50 | Biotium | 50uL | 474 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), 1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC050532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC050532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC700532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC700532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC800532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC800532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCB0532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCB0532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC940532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC940532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC550532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC550532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCH0532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNCH0532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC470532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC470532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) polyclonal antibody |
|||
ABP-PAB-11625 | Allele Biotech | 100 ug | Ask for price |
Cytokeratin 14 (KRT14) Rabbit mAb |
|||
A19039 | Abclonal | 20 μL | 18 EUR |
Anti-Cytokeratin 14/KRT14 Antibody |
|||
A01432 | BosterBio | 100ug/vial | 400.8 EUR |
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC040532-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14(KRT14/532) Antibody |
|||
BNC040532-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 Antibody (CK14, KRT14) |
|||
R32606 | NSJ Bioreagents | 100 ug | 419 EUR |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
RQ4995 | NSJ Bioreagents | 100ul | 419 EUR |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
RQ5076 | NSJ Bioreagents | 100ul | 419 EUR |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V7917-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V7917-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V7917SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2175-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2175-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2175BTN | NSJ Bioreagents | 500 ul | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2175IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2175SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V7121-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V7121-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V7121IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V7121SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2668-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2668-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2668IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V2668SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9058-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9058-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9058IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9058SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9313-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9313-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9313SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9315-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9315-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9315SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9319-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. It is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9319-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: Cytokeratin 14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. It is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9319SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. It is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9407-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 (CK14, KRT14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). KRT14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9407-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: Cytokeratin 14 (CK14, KRT14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). KRT14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V9407SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: Cytokeratin 14 (CK14, KRT14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). KRT14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4029-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4029-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4029SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4032-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 is a member of the type I keratin family of intermediate filament proteins. It always pairs with the type II keratin K5 and form the primary keratin pair of the keratinocytes of stratified squamous epithelia, including the epidermis as well as mucosal non-keratinizing stratified squamous epithelia. Cytokeratin 14 is strongly expressed in the undifferentiated basal cell layer containing the stem cells and are down-regulated in the differentiating suprabasal cell layers. Otherwise, in the widely well stratified follicular outer root sheath, cytokeratin 14 is uniformly expressed throughout all layers. The expression spectrum of cytokeratin 14 in tumors corresponds well to the patterns in normal epithelia. Thus, most squamous cell carcinomas as well as malignant mesotheliomas strongly express this keratin whereas little, focal, or no expression is found in adenocarcinomas. Cytokeratin 14 may be a useful marker in the differential diagnosis of squamous cell carcinoma from other epithelial tumors. Recent studies also indicate that CK14 expression in breast cancer corresponded with poor clinical outcome and that CK14 may have diagnostic value in the sub-classification of NSCLC. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4032-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Cytokeratin 14 is a member of the type I keratin family of intermediate filament proteins. It always pairs with the type II keratin K5 and form the primary keratin pair of the keratinocytes of stratified squamous epithelia, including the epidermis as well as mucosal non-keratinizing stratified squamous epithelia. Cytokeratin 14 is strongly expressed in the undifferentiated basal cell layer containing the stem cells and are down-regulated in the differentiating suprabasal cell layers. Otherwise, in the widely well stratified follicular outer root sheath, cytokeratin 14 is uniformly expressed throughout all layers. The expression spectrum of cytokeratin 14 in tumors corresponds well to the patterns in normal epithelia. Thus, most squamous cell carcinomas as well as malignant mesotheliomas strongly express this keratin whereas little, focal, or no expression is found in adenocarcinomas. Cytokeratin 14 may be a useful marker in the differential diagnosis of squamous cell carcinoma from other epithelial tumors. Recent studies also indicate that CK14 expression in breast cancer corresponded with poor clinical outcome and that CK14 may have diagnostic value in the sub-classification of NSCLC. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4032SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 is a member of the type I keratin family of intermediate filament proteins. It always pairs with the type II keratin K5 and form the primary keratin pair of the keratinocytes of stratified squamous epithelia, including the epidermis as well as mucosal non-keratinizing stratified squamous epithelia. Cytokeratin 14 is strongly expressed in the undifferentiated basal cell layer containing the stem cells and are down-regulated in the differentiating suprabasal cell layers. Otherwise, in the widely well stratified follicular outer root sheath, cytokeratin 14 is uniformly expressed throughout all layers. The expression spectrum of cytokeratin 14 in tumors corresponds well to the patterns in normal epithelia. Thus, most squamous cell carcinomas as well as malignant mesotheliomas strongly express this keratin whereas little, focal, or no expression is found in adenocarcinomas. Cytokeratin 14 may be a useful marker in the differential diagnosis of squamous cell carcinoma from other epithelial tumors. Recent studies also indicate that CK14 expression in breast cancer corresponded with poor clinical outcome and that CK14 may have diagnostic value in the sub-classification of NSCLC. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4060-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 is a member of the type I keratin family of intermediate filament proteins. It always pairs with the type II keratin K5 and form the primary keratin pair of the keratinocytes of stratified squamous epithelia, including the epidermis as well as mucosal non-keratinizing stratified squamous epithelia. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4060-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Cytokeratin 14 is a member of the type I keratin family of intermediate filament proteins. It always pairs with the type II keratin K5 and form the primary keratin pair of the keratinocytes of stratified squamous epithelia, including the epidermis as well as mucosal non-keratinizing stratified squamous epithelia. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4060SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 is a member of the type I keratin family of intermediate filament proteins. It always pairs with the type II keratin K5 and form the primary keratin pair of the keratinocytes of stratified squamous epithelia, including the epidermis as well as mucosal non-keratinizing stratified squamous epithelia. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4062-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4062-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 Antibody / CK14 / KRT14 |
|||
V4062SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCA0284-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), APC conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCAP0284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCAP0284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC610284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC610284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC680284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC680284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCR0284-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), RPE conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNUB0284-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Concentration: 0.2mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNUB0284-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Concentration: 0.2mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC430284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC430284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC470284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC470284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC400284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC400284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC880284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC880284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC810284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC810284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCP0284-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNUM0284-50 | Biotium | 50uL | 474 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), 1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC050284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC050284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC700284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC700284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC800284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC800284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCB0284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCB0284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC940284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC940284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC550284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC550284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCH0284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNCH0284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC040284-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|||
BNC040284-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Heart Lysate (14 Days Old) |
|||
1401-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Heart tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Lung Lysate (14 Days Old) |
|||
1402-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Lung tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Brain Lysate (14 Days Old) |
|||
1403-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Brain tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Liver Lysate (14 Days Old) |
|||
1404-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Liver tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Kidney Lysate (14 Days Old) |
|||
1405-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Kidney tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Spleen Lysate (14 Days Old) |
|||
1406-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Spleen tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Thymus Lysate (14 Days Old) |
|||
1409-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Thymus tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Stomach Lysate (14 Day Old) |
|||
1415-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Stomach tissue lysate (14 Day Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Skin Lysate (14 Days Old) |
|||
1419-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Skin tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Eye Lysate (14 Days Old) |
|||
1420-14 | ProSci | 0.1 mg | 229.2 EUR |
Description: Eye tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Polyclonal KRT14 / CK14 / Cytokeratin 14 Antibody |
|||
APR03031G | Leading Biology | 0.1ml | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human KRT14 / CK14 / Cytokeratin 14 . This antibody is tested and proven to work in the following applications: |
|||
Keratin 14 Blocking Peptide |
|||
AF5225-BP | Affbiotech | 1mg | 234 EUR |
Keratin 14 Blocking Peptide |
|||
AF5370-BP | Affbiotech | 1mg | 234 EUR |
Keratin 14 Blocking Peptide |
|||
AF0736-BP | Affbiotech | 1mg | 234 EUR |
Anti-Keratin 14 antibody |
|||
STJ16100264 | St John's Laboratory | 100 µg | 535.2 EUR |
Anti-Keratin 14 antibody |
|||
STJ16100290 | St John's Laboratory | 1 mL | 535.2 EUR |
Anti-Keratin 14 antibody |
|||
STJ16101021 | St John's Laboratory | 100 µg | 424.8 EUR |
Keratin 14 Colorimetric Cell-Based ELISA |
|||
EKC1610 | BosterBio | 100ul | 686.4 EUR |
KRT14 ELISA Kit (Human) (OKAN05824) |
|||
OKAN05824 | Aviva Systems Biology | 96 Wells | 950.4 EUR |
Description: Description of target: This gene encodes a member of the keratin family, the most diverse group of intermediate filaments. This gene product, a type I keratin, is usually found as a heterotetramer with two keratin 5 molecules, a type II keratin. Together they form the cytoskeleton of epithelial cells. Mutations in the genes for these keratins are associated with epidermolysis bullosa simplex. At least one pseudogene has been identified at 17p12-p11.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.059 ng/mL |
|||
KRT14 ELISA Kit (Human) (OKCD00245) |
|||
OKCD00245 | Aviva Systems Biology | 96 Wells | 950.4 EUR |
Description: Description of target: The nonhelical tail domain is involved in promoting KRT5-KRT14 filaments to self-organize into large bundles and enhances the mechanical properties involved in resilience of keratin intermediate filaments in vitro.1 Publication
<p>Manually curated information for which there is published experimental evidence.</p>
<p><a href="/manual/evidences#ECO:0000269">More…</a></p> Manual assertion based on experiment iniRef.13"The nonhelical tail domain of keratin 14 promotes filament bundling and enhances the mechanical properties of keratin intermediate filaments in vitro."_x005F_x005F_x000D_Bousquet O., Ma L., Yamada S., Gu C., Idei T., Takahashi K., Wirtz D., Coulombe P.A._x005F_x005F_x000D_J. Cell Biol. 155:747-754(2001) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH KERATIN FILAMENTS, SUBCELLULAR LOCATION. ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.059 ng/mL |
|||
KRT14 ELISA Kit (Human) (OKDD00362) |
|||
OKDD00362 | Aviva Systems Biology | 96 Wells | 1059.6 EUR |
Description: Description of target: This gene encodes a member of the keratin family, the most diverse group of intermediate filaments. This gene product, a type I keratin, is usually found as a heterotetramer with two keratin 5 molecules, a type II keratin. Together they form the cytoskeleton of epithelial cells. Mutations in the genes for these keratins are associated with epidermolysis bullosa simplex. At least one pseudogene has been identified at 17p12-p11.;Species reactivity: Human;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: < 0.053 ng/mL |
|||
Monoclonal Cytokeratin 14 (KRT14) (Squamous Cell Marker) Antibody, Clone: KRT14/532 |
|||
AMM00976G | Leading Biology | 7 ml | 580.8 EUR |
Description: A Monoclonal antibody against Human Cytokeratin 14 (KRT14) (Squamous Cell Marker). The antibodies are raised in Mouse and are from clone KRT14/532. This antibody is applicable in IHC, IF, FC |
|||
Keratin 14 Colorimetric Cell-Based ELISA Kit (OKAG01128) |
|||
OKAG01128 | Aviva Systems Biology | 96 Wells | 715.2 EUR |
Description: Description of target: ;Species reactivity: Human, Mouse, Rat;Application: ELISA;Assay info: Assay Type: Cell-Based Subtype: None Detection Method: Colorimetric 450 nm;Sensitivity: |
|||
Mouse Keratin- associated protein 14, Krtap14 ELISA KIT |
|||
ELI-46523m | Lifescience Market | 96 Tests | 1038 EUR |
KRT14 Human, Cytokeratin 14 Human Recombinant Protein, His Tag |
|||
PROTP02533-1 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: KRT14 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 492 amino acids (1-472 a.a.) and having a molecular mass of 53.8kDa.;KRT14 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Anti-Keratin 5+14 antibody |
|||
STJ16101016 | St John's Laboratory | 100 µg | 424.8 EUR |
Anti-Keratin 14+17 antibody |
|||
STJ16101022 | St John's Laboratory | 100 µg | 424.8 EUR |
TSH (Thyrotrophin) ELISA test |
|||
14 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of TSH (Thyrotrophin) |
|||
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed |
|||
ELISA-1 | Alpha Diagnostics | 1 | 242.4 EUR |
Human Keratin 14 Differentiation Reporter (pGreenZeo, Plasmid) |
|||
SR10038PA-1 | SBI | 10 ug | 2098.8 EUR |
Human Keratin 14 Differentiation Reporter (pGreenZeo, Virus) |
|||
SR10038VA-1 | SBI | >2 x 10^6 IFUs | 906 EUR |
Monoclonal KRT14 / CK14 / Cytokeratin 14 Antibody (C-Terminus) |
|||
AMM01762G | Leading Biology | 10.05ml | 580.8 EUR |
Description: A Monoclonal antibody against Human KRT14 / CK14 / Cytokeratin 14 (C-Terminus). The antibodies are raised in Mouse. This antibody is applicable in WB and IHC-P |
|||
Polyclonal KRT14 / CK14 / Cytokeratin 14 Antibody (C-Terminus) |
|||
APR02747G | Leading Biology | 0.1ml | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human KRT14 / CK14 / Cytokeratin 14 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Anti-Cytokeratin 14 Antibody Clone KRT14/532, Unconjugated-100ug |
|||
3861-MSM3-P1 | EnQuireBio | 100ug | 513.6 EUR |
Anti-Cytokeratin 14 (KRT14) (Squamous Cell Marker) Monoclonal Antibody |
|||
M01432 | BosterBio | 100ug/vial | 476.4 EUR |
Description: Mouse Monoclonal Cytokeratin 14 (KRT14) (Squamous Cell Marker) Antibody. Validated in IHC and tested in Human, Mouse, Rat. |
|||
Cytokeratin 14 (KRT14) (Squamous Cell Marker); Clone LL002 (Concentrate) |
|||
RA0181-C.1 | ScyTek Laboratories | 0.1 ml | 150 EUR |
Cytokeratin 14 (KRT14) (Squamous Cell Marker); Clone LL002 (Concentrate) |
|||
RA0181-C.5 | ScyTek Laboratories | 0.5 ml | 360 EUR |
Monoclonal Cytokeratin 14 (KRT14) (Squamous Cell Marker) Antibody - With BSA and Azide, Clone: KRT14/284 |
|||
AMM00974G | Leading Biology | 0.05mg | 475.2 EUR |
Description: A Monoclonal antibody against Human Cytokeratin 14 (KRT14) (Squamous Cell Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone KRT14/284. This antibody is applicable in IF, FC |
Human KRT14(Keratin 14) ELISA Kit